m-Chlorophenylpiperazine decreases food intake in a test meal

We studied the effect of the 5-HT receptor agonist, m-chlorophenylpiperazine (mCPP) (0.4 mg/kg), on food intake in 12 healthy female volunteers, in a double-blind placebo controlled design. Compared to placebo, mCPP significantly lowered food intake in a test meal. Treatment with mCPP also caused si...

Full description

Saved in:
Bibliographic Details
Published in:Psychopharmacologia 1994-09, Vol.116 (1), p.120-122
Main Authors: WALSH, A. E. S, SMITH, K. A, OLDMAN, A. D, WILLIAMS, C, GOODALL, E. M, COWEN, P. J
Format: Article
Language:English
Subjects:
Adult
Biological and medical sciences
Depression, Chemical
Double-Blind Method
Eating - drug effects
Female
General and cellular metabolism. Vitamins
Humans
Hunger - drug effects
Medical sciences
Pharmacology. Drug treatments
Piperazines - adverse effects
Piperazines - pharmacology
Serotonin Receptor Agonists - adverse effects
Serotonin Receptor Agonists - pharmacology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c311t-38941579a999702d54e2a32afa9b8663680df2ac645a2a84dbcf5c685b31a7e73
cites cdi_FETCH-LOGICAL-c311t-38941579a999702d54e2a32afa9b8663680df2ac645a2a84dbcf5c685b31a7e73
container_end_page 122
container_issue 1
container_start_page 120
container_title Psychopharmacologia
container_volume 116
creator WALSH, A. E. S
SMITH, K. A
OLDMAN, A. D
WILLIAMS, C
GOODALL, E. M
COWEN, P. J
description We studied the effect of the 5-HT receptor agonist, m-chlorophenylpiperazine (mCPP) (0.4 mg/kg), on food intake in 12 healthy female volunteers, in a double-blind placebo controlled design. Compared to placebo, mCPP significantly lowered food intake in a test meal. Treatment with mCPP also caused significant increases in ratings of nausea and light-headedness, though these effects had remitted by the time of the test meal. The results suggest that activation of brain 5-HT2C receptors may lower food intake in humans; it is also possible, however, that the hypophagic effect of mCPP in the present study could be a consequence of its adverse subjective side effects.
doi_str_mv 10.1007/BF02244883
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_16811390</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16811390</sourcerecordid><originalsourceid>FETCH-LOGICAL-c311t-38941579a999702d54e2a32afa9b8663680df2ac645a2a84dbcf5c685b31a7e73</originalsourceid><addsrcrecordid>eNpFkDtPwzAUhS0EKqWwsCNlQAxIAb-S2AMDVLykSiwwRzfOtRpwHtjpUH49Ro3KXc5wPp0rfYScM3rDKC1uH54o51IqJQ7InEnBU04LfkjmlAqRCpapY3ISwieNJ5WckVmhcq55Nid3bbpcu973wxq7rRuaAT38NB0mNRqPEDAktu_rpOlG-MIYCSQjhjFpEdwpObLgAp5NuSAfT4_vy5d09fb8urxfpUYwNqZCacmyQoPWuqC8ziRyEBws6ErlucgVrS0Hk8sMOChZV8ZmJldZJRgUWIgFudrtDr7_3sTvZdsEg85Bh_0mlCxXjAlNI3i9A43vQ_Boy8E3LfhtyWj556r8dxXhi2l1U7VY79FJTuwvpx6CAWc9dKYJe0xyJmS0_QtOb278</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16811390</pqid></control><display><type>article</type><title>m-Chlorophenylpiperazine decreases food intake in a test meal</title><source>Springer Online Journals Archive Complete</source><creator>WALSH, A. E. S ; SMITH, K. A ; OLDMAN, A. D ; WILLIAMS, C ; GOODALL, E. M ; COWEN, P. J</creator><creatorcontrib>WALSH, A. E. S ; SMITH, K. A ; OLDMAN, A. D ; WILLIAMS, C ; GOODALL, E. M ; COWEN, P. J</creatorcontrib><description>We studied the effect of the 5-HT receptor agonist, m-chlorophenylpiperazine (mCPP) (0.4 mg/kg), on food intake in 12 healthy female volunteers, in a double-blind placebo controlled design. Compared to placebo, mCPP significantly lowered food intake in a test meal. Treatment with mCPP also caused significant increases in ratings of nausea and light-headedness, though these effects had remitted by the time of the test meal. The results suggest that activation of brain 5-HT2C receptors may lower food intake in humans; it is also possible, however, that the hypophagic effect of mCPP in the present study could be a consequence of its adverse subjective side effects.</description><identifier>ISSN: 0033-3158</identifier><identifier>EISSN: 1432-2072</identifier><identifier>DOI: 10.1007/BF02244883</identifier><identifier>PMID: 7862925</identifier><identifier>CODEN: PSYPAG</identifier><language>eng</language><publisher>Berlin: Springer</publisher><subject>Adult ; Biological and medical sciences ; Depression, Chemical ; Double-Blind Method ; Eating - drug effects ; Female ; General and cellular metabolism. Vitamins ; Humans ; Hunger - drug effects ; Medical sciences ; Pharmacology. Drug treatments ; Piperazines - adverse effects ; Piperazines - pharmacology ; Serotonin Receptor Agonists - adverse effects ; Serotonin Receptor Agonists - pharmacology</subject><ispartof>Psychopharmacologia, 1994-09, Vol.116 (1), p.120-122</ispartof><rights>1994 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c311t-38941579a999702d54e2a32afa9b8663680df2ac645a2a84dbcf5c685b31a7e73</citedby><cites>FETCH-LOGICAL-c311t-38941579a999702d54e2a32afa9b8663680df2ac645a2a84dbcf5c685b31a7e73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4213414$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7862925$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>WALSH, A. E. S</creatorcontrib><creatorcontrib>SMITH, K. A</creatorcontrib><creatorcontrib>OLDMAN, A. D</creatorcontrib><creatorcontrib>WILLIAMS, C</creatorcontrib><creatorcontrib>GOODALL, E. M</creatorcontrib><creatorcontrib>COWEN, P. J</creatorcontrib><title>m-Chlorophenylpiperazine decreases food intake in a test meal</title><title>Psychopharmacologia</title><addtitle>Psychopharmacology (Berl)</addtitle><description>We studied the effect of the 5-HT receptor agonist, m-chlorophenylpiperazine (mCPP) (0.4 mg/kg), on food intake in 12 healthy female volunteers, in a double-blind placebo controlled design. Compared to placebo, mCPP significantly lowered food intake in a test meal. Treatment with mCPP also caused significant increases in ratings of nausea and light-headedness, though these effects had remitted by the time of the test meal. The results suggest that activation of brain 5-HT2C receptors may lower food intake in humans; it is also possible, however, that the hypophagic effect of mCPP in the present study could be a consequence of its adverse subjective side effects.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Depression, Chemical</subject><subject>Double-Blind Method</subject><subject>Eating - drug effects</subject><subject>Female</subject><subject>General and cellular metabolism. Vitamins</subject><subject>Humans</subject><subject>Hunger - drug effects</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Piperazines - adverse effects</subject><subject>Piperazines - pharmacology</subject><subject>Serotonin Receptor Agonists - adverse effects</subject><subject>Serotonin Receptor Agonists - pharmacology</subject><issn>0033-3158</issn><issn>1432-2072</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><recordid>eNpFkDtPwzAUhS0EKqWwsCNlQAxIAb-S2AMDVLykSiwwRzfOtRpwHtjpUH49Ro3KXc5wPp0rfYScM3rDKC1uH54o51IqJQ7InEnBU04LfkjmlAqRCpapY3ISwieNJ5WckVmhcq55Nid3bbpcu973wxq7rRuaAT38NB0mNRqPEDAktu_rpOlG-MIYCSQjhjFpEdwpObLgAp5NuSAfT4_vy5d09fb8urxfpUYwNqZCacmyQoPWuqC8ziRyEBws6ErlucgVrS0Hk8sMOChZV8ZmJldZJRgUWIgFudrtDr7_3sTvZdsEg85Bh_0mlCxXjAlNI3i9A43vQ_Boy8E3LfhtyWj556r8dxXhi2l1U7VY79FJTuwvpx6CAWc9dKYJe0xyJmS0_QtOb278</recordid><startdate>19940901</startdate><enddate>19940901</enddate><creator>WALSH, A. E. S</creator><creator>SMITH, K. A</creator><creator>OLDMAN, A. D</creator><creator>WILLIAMS, C</creator><creator>GOODALL, E. M</creator><creator>COWEN, P. J</creator><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QR</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>19940901</creationdate><title>m-Chlorophenylpiperazine decreases food intake in a test meal</title><author>WALSH, A. E. S ; SMITH, K. A ; OLDMAN, A. D ; WILLIAMS, C ; GOODALL, E. M ; COWEN, P. J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c311t-38941579a999702d54e2a32afa9b8663680df2ac645a2a84dbcf5c685b31a7e73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Depression, Chemical</topic><topic>Double-Blind Method</topic><topic>Eating - drug effects</topic><topic>Female</topic><topic>General and cellular metabolism. Vitamins</topic><topic>Humans</topic><topic>Hunger - drug effects</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Piperazines - adverse effects</topic><topic>Piperazines - pharmacology</topic><topic>Serotonin Receptor Agonists - adverse effects</topic><topic>Serotonin Receptor Agonists - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>WALSH, A. E. S</creatorcontrib><creatorcontrib>SMITH, K. A</creatorcontrib><creatorcontrib>OLDMAN, A. D</creatorcontrib><creatorcontrib>WILLIAMS, C</creatorcontrib><creatorcontrib>GOODALL, E. M</creatorcontrib><creatorcontrib>COWEN, P. J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Psychopharmacologia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>WALSH, A. E. S</au><au>SMITH, K. A</au><au>OLDMAN, A. D</au><au>WILLIAMS, C</au><au>GOODALL, E. M</au><au>COWEN, P. J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>m-Chlorophenylpiperazine decreases food intake in a test meal</atitle><jtitle>Psychopharmacologia</jtitle><addtitle>Psychopharmacology (Berl)</addtitle><date>1994-09-01</date><risdate>1994</risdate><volume>116</volume><issue>1</issue><spage>120</spage><epage>122</epage><pages>120-122</pages><issn>0033-3158</issn><eissn>1432-2072</eissn><coden>PSYPAG</coden><abstract>We studied the effect of the 5-HT receptor agonist, m-chlorophenylpiperazine (mCPP) (0.4 mg/kg), on food intake in 12 healthy female volunteers, in a double-blind placebo controlled design. Compared to placebo, mCPP significantly lowered food intake in a test meal. Treatment with mCPP also caused significant increases in ratings of nausea and light-headedness, though these effects had remitted by the time of the test meal. The results suggest that activation of brain 5-HT2C receptors may lower food intake in humans; it is also possible, however, that the hypophagic effect of mCPP in the present study could be a consequence of its adverse subjective side effects.</abstract><cop>Berlin</cop><pub>Springer</pub><pmid>7862925</pmid><doi>10.1007/BF02244883</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0033-3158
ispartof Psychopharmacologia, 1994-09, Vol.116 (1), p.120-122
issn 0033-3158
1432-2072
language eng
recordid cdi_proquest_miscellaneous_16811390
source Springer Online Journals Archive Complete
subjects Adult
Biological and medical sciences
Depression, Chemical
Double-Blind Method
Eating - drug effects
Female
General and cellular metabolism. Vitamins
Humans
Hunger - drug effects
Medical sciences
Pharmacology. Drug treatments
Piperazines - adverse effects
Piperazines - pharmacology
Serotonin Receptor Agonists - adverse effects
Serotonin Receptor Agonists - pharmacology
title m-Chlorophenylpiperazine decreases food intake in a test meal
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T02%3A55%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=m-Chlorophenylpiperazine%20decreases%20food%20intake%20in%20a%20test%20meal&rft.jtitle=Psychopharmacologia&rft.au=WALSH,%20A.%20E.%20S&rft.date=1994-09-01&rft.volume=116&rft.issue=1&rft.spage=120&rft.epage=122&rft.pages=120-122&rft.issn=0033-3158&rft.eissn=1432-2072&rft.coden=PSYPAG&rft_id=info:doi/10.1007/BF02244883&rft_dat=%3Cproquest_cross%3E16811390%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c311t-38941579a999702d54e2a32afa9b8663680df2ac645a2a84dbcf5c685b31a7e73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=16811390&rft_id=info:pmid/7862925&rfr_iscdi=true